AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34991472 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Photo-Activity
Number of subjects: 90
Study 34991472 — intervention group
Group type: COMPARATOR
Intervention: Control activity
Number of subjects: 90
Study 34006055 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% Hypertonic saline (HS) solution
Number of subjects: 40
Study 34006055 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's (LR) solution
Number of subjects: 40
Study 34953787 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O
Number of subjects: 60
Study 34953787 — intervention group
Group type: COMPARATOR
Intervention: Argon
Number of subjects: 60
Study 36212187 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide plus ADT
Number of subjects: 90
Study 36212187 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide
Number of subjects: 90
Study 36212187 — intervention group
Group type: EXPERIMENTAL
Intervention: ADT
Number of subjects: 90
Study 36212187 — intervention group
Group type: COMPARATOR
Intervention: Overall population
Number of subjects: 90
Study 36212187 — intervention group
Group type: COMPARATOR
Intervention: Apalutamide plus ADT, Apalutamide, ADT
Number of subjects: 90
Study 32198561 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-item stigma measure
Number of subjects: 1263
Study 35334570 — intervention group
Group type: EXPERIMENTAL
Intervention: L-alanyl L-glutamine dipeptide
Number of subjects: 44
Study 35334570 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 33831213 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (2 mg, subcutaneously, once-weekly)
Number of subjects: 84
Study 33831213 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 33831213 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT, 21 mg)
Number of subjects: 84
Study 35804410 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing speed training interventions with varying attentional control demands (choice reaction time, switching, dual tasks)
Number of subjects: 400
Study 35804410 — intervention group
Group type: COMPARATOR
Intervention: Active control group training simple reaction time tasks with minimal attentional control demands
Number of subjects: 400
Study 34841427 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet quiz game intervention
Number of subjects: 4294
Study 34841427 — intervention group
Group type: COMPARATOR
Intervention: Conventional health education
Number of subjects: 4294
Study 35354662 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive quality improvement intervention 'STEP' (Strategies, Toolkit, Exploration, Paradigm)
Number of subjects: 7644
Study 35354662 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 7644
Study 34311697 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician support package comprising face‐to‐face sessions, group discussion, simulated consultations, patient vignettes, and model consultation videos
Number of subjects: 0
Study 34311697 — intervention group
Group type: EXPERIMENTAL
Intervention: Support from senior clinicians
Number of subjects: 0
Study 34311697 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring of GP performance and provision of regular feedback
Number of subjects: 0
Study 34916380 — intervention group
Group type: EXPERIMENTAL
Intervention: TJ-107
Number of subjects: 0
Study 34867725 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Prism Adaptation (PA-c)
Number of subjects: 24
Study 34867725 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Prism Adaptation (PA-i)
Number of subjects: 24
Study 34867725 — intervention group
Group type: COMPARATOR
Intervention: Passive treatment (historical control)
Number of subjects: 24
Study 34867725 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (historical control)
Number of subjects: 24
Study 34867725 — intervention group
Group type: COMPARATOR
Intervention: Prism Adaptation treatment with fewer therapy sessions (historical control)
Number of subjects: 24
Study 34758057 — intervention group
Group type: COMPARATOR
Intervention: High flow: 70 l · min‐1, continuous jaw thrust
Number of subjects: 125
Study 34758057 — intervention group
Group type: COMPARATOR
Intervention: Medium flow: 10 l · min‐1, continuous jaw thrust
Number of subjects: 125
Study 34758057 — intervention group
Group type: COMPARATOR
Intervention: Low flow: 2 l · min‐1, continuous jaw thrust
Number of subjects: 125
Study 34758057 — intervention group
Group type: COMPARATOR
Intervention: Minimal flow: 0.25 l · min‐1, endotracheal tube
Number of subjects: 125
Study 33784688 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 264
Study 33784688 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture + Tropisetron
Number of subjects: 264
Study 33784688 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron
Number of subjects: 264
Study 33784688 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 264
Study 35938348 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy for insomnia (CBT‐I)
Number of subjects: 112
Study 35938348 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 112
Study 34362525 — intervention group
Group type: EXPERIMENTAL
Intervention: Non ABO‐HDN patients
Number of subjects: 67
Study 34362525 — intervention group
Group type: EXPERIMENTAL
Intervention: Non ABO‐HDN direct antibody test
Number of subjects: 67
Study 33932000 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with moxibustion (seed-sized moxa cone)
Number of subjects: 60
Study 33932000 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine hydrochloride capsule 20 mg once a day
Number of subjects: 60
Study 35603590 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibre supplementation (wheat bran, pectin, green banana flour)
Number of subjects: 20
Study 35603590 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibre/water (2 l/day)
Number of subjects: 20
Study 35603590 — intervention group
Group type: COMPARATOR
Intervention: Fibre
Number of subjects: 20
Study 32065967 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine bathing
Number of subjects: 312
Study 32065967 — intervention group
Group type: COMPARATOR
Intervention: Soap-and-water bathing
Number of subjects: 312
Study 36401501 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG) supplementation during the first 6 months of life
Number of subjects: 184
Study 36401501 — intervention group
Group type: COMPARATOR
Intervention: Control group (no LGG supplementation)
Number of subjects: 184
Study 33616613 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 327
Study 33616613 — intervention group
Group type: COMPARATOR
Intervention: Education-only control (EOC)
Number of subjects: 327
Study 32876697 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose hydrocortisone (50 mg or 100 mg every 6 hours)
Number of subjects: 384
Study 32876697 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock-dependent hydrocortisone (50 mg every 6 hours when shock was clinically evident)
Number of subjects: 384
Study 32876697 — intervention group
Group type: COMPARATOR
Intervention: No hydrocortisone
Number of subjects: 384
Study 36009980 — intervention group
Group type: EXPERIMENTAL
Intervention: Colistin combined with sulbactam at 12 g/day
Number of subjects: 88
Study 36009980 — intervention group
Group type: COMPARATOR
Intervention: Colistin combined with sulbactam at 9 g/day
Number of subjects: 88
Study 32617651 — intervention group
Group type: EXPERIMENTAL
Intervention: Subchondral cell therapy (20 mL of bone marrow concentrate with 5727 MSCs/mL)
Number of subjects: 60
Study 32617651 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular cell therapy (20 mL of bone marrow concentrate with 5727 MSCs/mL)
Number of subjects: 60
Study 35330416 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 102
Study 35330416 — intervention group
Group type: COMPARATOR
Intervention: Control (Saline)
Number of subjects: 102
Study 32202692 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (64 IU total, 40 IU followed by 24 IU after 80 minutes)
Number of subjects: 52
Study 32202692 — intervention group
Group type: COMPARATOR
Intervention: Placebo (administered in the same dosing schedule as oxytocin)
Number of subjects: 52
Study 35631293 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD (30 mg)
Number of subjects: 14
Study 35631293 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD (30 mg) with food
Number of subjects: 14
Study 35631293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 33931829 — intervention group
Group type: EXPERIMENTAL
Intervention: Peloid therapy + home exercise program
Number of subjects: 106
Study 33931829 — intervention group
Group type: COMPARATOR
Intervention: Home exercise program
Number of subjects: 106
Study 33428148 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance with nerve stimulation (group U-N)
Number of subjects: 44
Study 33428148 — intervention group
Group type: COMPARATOR
Intervention: Nerve stimulation alone (group N)
Number of subjects: 44
Study 35000098 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose paltusotine 1.25 to 20 mg
Number of subjects: 41
Study 35000098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 35000098 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose paltusotine 5 to 30 mg administered once daily for 10 days
Number of subjects: 41
Study 34189636 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabectedin 1.1 mg/m2 plus pegylated liposomal doxorubicin (PLD) 30 mg/m2, administered intravenously every 21 days until disease progression or unacceptable toxicity.
Number of subjects: 18
Study 32075887 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) tailored to habitual energy intakes (MedD)
Number of subjects: 82
Study 32075887 — intervention group
Group type: COMPARATOR
Intervention: Regular diets (ConD)
Number of subjects: 82
Study 35398981 — intervention group
Group type: EXPERIMENTAL
Intervention: First-Person Perspective Action Observation training
Number of subjects: 20
Study 35398981 — intervention group
Group type: COMPARATOR
Intervention: Third-Person Perspective Action Observation training
Number of subjects: 20
Study 33325768 — intervention group
Group type: EXPERIMENTAL
Intervention: Scared-straight flipcharts with salient information about disease severity and cash incentives
Number of subjects: 1660
Study 33325768 — intervention group
Group type: COMPARATOR
Intervention: Control flipcharts with written explanation about the severity of the disease
Number of subjects: 1660
Study 34001178 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone application (MPA)
Number of subjects: 0
Study 32062765 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU) intervention
Number of subjects: 709
Study 34376082 — intervention group
Group type: EXPERIMENTAL
Intervention: Vignette-based studies assessing victim blaming
Number of subjects: 3
Study 34376082 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal attribution statement for rape or theft
Number of subjects: 3
Study 34376082 — intervention group
Group type: EXPERIMENTAL
Intervention: Social reactions reported by interpersonal trauma survivors
Number of subjects: 3
Study 34376082 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal trauma responses
Number of subjects: 3
Study 33026537 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-fragmented adipose tissue injection
Number of subjects: 20
Study 35289500 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil/amlodipine besylate tablet (20 mg/5 mg) under fasting conditions
Number of subjects: 56
Study 35289500 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil/amlodipine besylate tablet (20 mg/5 mg) under fed conditions
Number of subjects: 56
Study 35289500 — intervention group
Group type: COMPARATOR
Intervention: Control group (fed condition)
Number of subjects: 56
Study 32165403 — intervention group
Group type: EXPERIMENTAL
Intervention: FENO guided treatment (not treated with LTRA)
Number of subjects: 1112
Study 32165403 — intervention group
Group type: EXPERIMENTAL
Intervention: FENO guided treatment (non-obese children)
Number of subjects: 1112
Study 35652746 — intervention group
Group type: EXPERIMENTAL
Intervention: Centanafadine 200 mg/d
Number of subjects: 1000
Study 35652746 — intervention group
Group type: EXPERIMENTAL
Intervention: Centanafadine 400 mg/d
Number of subjects: 1000
Study 35652746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 33528901 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised mixed management intervention (4 sessions of face-to-face lactation education and psychoeducation)
Number of subjects: 182
Study 33528901 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 182
Study 33528901 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised mixed management intervention
Number of subjects: 182
Study 32730283 — intervention group
Group type: EXPERIMENTAL
Intervention: Glidescope® Go™
Number of subjects: 112
Study 32730283 — intervention group
Group type: EXPERIMENTAL
Intervention: Dahlhausen VL
Number of subjects: 112
Study 32730283 — intervention group
Group type: EXPERIMENTAL
Intervention: King Vision™
Number of subjects: 112
Study 32730283 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 112
Study 32730283 — intervention group
Group type: EXPERIMENTAL
Intervention: Glidescope® Go™ and Dahlhausen VL
Number of subjects: 112
Study 32730283 — intervention group
Group type: EXPERIMENTAL
Intervention: I-View™
Number of subjects: 112
Study 36272502 — intervention group
Group type: EXPERIMENTAL
Intervention: DON group (10 mg DON/kg of feed)
Number of subjects: 24
Study 36272502 — intervention group
Group type: COMPARATOR
Intervention: Control group (mycotoxin-free diet)
Number of subjects: 24
Study 35831789 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-Intensive program
Number of subjects: 70
Study 35831789 — intervention group
Group type: COMPARATOR
Intervention: Light-load exercise program
Number of subjects: 70
Study 34297944 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-assisted endoscopy (AI-first group)
Number of subjects: 1812
Study 34297944 — intervention group
Group type: COMPARATOR
Intervention: Routine white light endoscopy (routine-first group)
Number of subjects: 1812
Study 33238245 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio tape application
Number of subjects: 19
Study 33238245 — intervention group
Group type: COMPARATOR
Intervention: Non-Kinesio tape (control)
Number of subjects: 19
Study 36199287 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing load while keeping repetitions constant (LOAD)
Number of subjects: 43
Study 36199287 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing repetitions while keeping load constant (REPS)
Number of subjects: 43
Study 36199287 — intervention group
Group type: COMPARATOR
Intervention: Both LOAD and REPS
Number of subjects: 43
Study 34408409 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT, n = 33)
Number of subjects: 105
Study 34408409 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Continuous Training (MICT, n = 24)
Number of subjects: 105
Study 34408409 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 48) following national physical activity guidelines
Number of subjects: 105
Study 32762663 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) at a fixed dose of 2.7 g/day (900 mg three times daily) for 12 weeks
Number of subjects: 126
Study 32762663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 32762663 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC)
Number of subjects: 126
Study 36321334 — intervention group
Group type: EXPERIMENTAL
Intervention: VSD combined with flap transplantation and immunosuppressive agent treatment
Number of subjects: 30
Study 36321334 — intervention group
Group type: COMPARATOR
Intervention: Normal dressing change combined with hormone and cyclosporine
Number of subjects: 30
Study 33763794 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine administration
Number of subjects: 91
Study 33763794 — intervention group
Group type: COMPARATOR
Intervention: Laser peripheral iridotomy (LPI)
Number of subjects: 91
Study 34133828 — intervention group
Group type: EXPERIMENTAL
Intervention: C. butyricum + 1,25(OH)2 D3 (CD)
Number of subjects: 360
Study 34133828 — intervention group
Group type: EXPERIMENTAL
Intervention: C. butyricum (Cb)
Number of subjects: 360
Study 34133828 — intervention group
Group type: EXPERIMENTAL
Intervention: C. butyricum (Cb) and C. butyricum + 1,25(OH)2 D3 (CD)
Number of subjects: 360
Study 34133828 — intervention group
Group type: COMPARATOR
Intervention: Control (Con)
Number of subjects: 360
Study 33039671 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial care for early fasting hyperglycaemia (n = 255)
Number of subjects: 523
Study 33039671 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial care for early fasting hyperglycaemia (n = 137, FPG ≥ 5.5 mmol/L)
Number of subjects: 523
Study 33992615 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipiflow treatment 3 weeks before cataract surgery
Number of subjects: 124
Study 33992615 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Lipiflow treatment)
Number of subjects: 124
Study 36110574 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-PD-1 immunotherapy (sintilimab) combined with gemcitabine chemotherapy
Number of subjects: 32
Study 34174189 — intervention group
Group type: EXPERIMENTAL
Intervention: Camrelizumab plus gemcitabine and cisplatin
Number of subjects: 263
Study 34174189 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus gemcitabine and cisplatin
Number of subjects: 263
Study 34174189 — intervention group
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Number of subjects: 263
Study 34174189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study 32438785 — intervention group
Group type: COMPARATOR
Intervention: Traditional Group (TG)
Number of subjects: 103
Study 32438785 — intervention group
Group type: COMPARATOR
Intervention: Intermittent Group (IG)
Number of subjects: 103
Study 32438785 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 103
Study 36434335 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVI with the balloon‐expandable Edwards Sapien 3
Number of subjects: 447
Study 36434335 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVI with the self‐expanding Medtronic Evolut R
Number of subjects: 447
Study 36434335 — intervention group
Group type: COMPARATOR
Intervention: None/trivial PVR
Number of subjects: 447
Study 36434335 — intervention group
Group type: COMPARATOR
Intervention: Trace PVR
Number of subjects: 447
Study 36434335 — intervention group
Group type: COMPARATOR
Intervention: Mild PVR
Number of subjects: 447
Study 36434335 — intervention group
Group type: COMPARATOR
Intervention: Moderate PVR
Number of subjects: 447
Study 36434335 — intervention group
Group type: COMPARATOR
Intervention: Severe PVR
Number of subjects: 447
Study 36434335 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic annular FD
Number of subjects: 447
Study 34147766 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure plus Placebo (PE + PLB)
Number of subjects: 195
Study 34147766 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline plus Enhanced Medication Management (SERT + EMM)
Number of subjects: 195
Study 34147766 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure plus Sertraline (PE + SERT)
Number of subjects: 195
Study 33150727 — intervention group
Group type: EXPERIMENTAL
Intervention: Homemade valved holding chamber (VHC)
Number of subjects: 20
Study 33150727 — intervention group
Group type: COMPARATOR
Intervention: Standard commercial valved holding chamber (Aerochamber®)
Number of subjects: 20
Study 35997590 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuina
Number of subjects: 104
Study 35997590 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 104
Study 33393847 — intervention group
Group type: EXPERIMENTAL
Intervention: NMU76-F1 methylation
Number of subjects: 1160
Study 33393847 — intervention group
Group type: EXPERIMENTAL
Intervention: GLR and lymphocyte numbers
Number of subjects: 1160
Study 35610575 — intervention group
Group type: EXPERIMENTAL
Intervention: Water (5 mL/kg)
Number of subjects: 20
Study 35610575 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate drink (5 mL/kg)
Number of subjects: 20
Study 36196715 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal softening PVC double‐lumen tube (DLT)
Number of subjects: 72
Study 36196715 — intervention group
Group type: COMPARATOR
Intervention: Single‐lumen tube (SLT)
Number of subjects: 72
Study 36048382 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous extract of seed of broccoli, dosage and duration not available
Number of subjects: 0
Study 33264737 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Fresno Test
Number of subjects: 50
Study 33140122 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingestion of inorganic nitrate (NO3−); specific dosage and duration not mentioned.
Number of subjects: 0
Study 34988975 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU
Number of subjects: 40
Study 34639532 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard 8-weeks MBSR training program
Number of subjects: 112
Study 34639532 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated 4-weeks MBSR training program
Number of subjects: 112
Study 34639532 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 112
Study 32164587 — intervention group
Group type: EXPERIMENTAL
Intervention: PEARL intervention
Number of subjects: 0
Study 32164587 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control)
Number of subjects: 0
Study 35180419 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole blood
Number of subjects: 3188
Study 35180419 — intervention group
Group type: COMPARATOR
Intervention: Packed cells
Number of subjects: 3188
Study 35180419 — intervention group
Group type: COMPARATOR
Intervention: Settled cells
Number of subjects: 3188
Study 34223142 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated film intervention
Number of subjects: 417
Study 34223142 — intervention group
Group type: COMPARATOR
Intervention: Control film
Number of subjects: 417